Related Experiment Video
Updated: Dec 10, 2025
05:39
Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
2.1K
Palliative sedation therapy for terminal movement disorders.
Daniel Kent Partain1, April Zehm2
1Center for Palliative Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA partain.daniel@mayo.edu.
BMJ Supportive & Palliative Care
|September 2, 2020
Summary
Palliative sedation therapy (PST) addresses refractory symptoms in terminally ill patients. This case explores ethical challenges and offers strategies to support clinicians facing moral distress with complex diagnoses.
Area of Science:
- Palliative Medicine
- Medical Ethics
Background:
- Palliative sedation therapy (PST) is utilized for refractory symptoms in terminally ill patients.
- Ethical justification for PST often relies on the principle of double effect.
- Clinicians may experience moral distress even when PST is indicated, such as for refractory cancer pain.
Observation:
- A unique case involved a patient with overlapping diagnoses: catatonia, medication-induced extrapyramidal symptoms, and dementia with Lewy bodies.
- Therapeutic options were limited due to the complexity of the patient's conditions.
- This situation highlights the challenges in decision-making for palliative care.
Findings:
- Existing ethical frameworks can be applied to complex PST cases.
- Practical strategies can support medical decision-making in challenging palliative sedation scenarios.
- Addressing overlapping diagnoses is crucial for effective palliative care.
Implications:
- This case provides insights into managing refractory symptoms in complex patients.
- Strategies discussed can help mitigate moral distress among healthcare providers.
- The study contributes to best practices in palliative sedation and end-of-life care.
More Related Videos
Related Concept Videos
01:24Parkinson's Disease: Treatment
815
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
815
01:31Skeletal Muscle Relaxants: Therapeutic Uses
781
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
781
01:21Skeletal Muscle Relaxants: Adverse Effects
673
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
673
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
377
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
377
01:22Stages of General Anesthesia
1.2K
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.2K
01:22Alzheimer's Disease: Treatment
640
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
640